5 Best Performing Biotech ETFs in 2024

3. Virtus LifeSci Biotech Products ETF (NYSE:BBP)

5-Year Share Price Performance as of April 20: 19.85%

The Virtus LifeSci Biotech Products ETF (NYSE:BBP) seeks to replicate the performance of the LifeSci Biotechnology Products Index, which tracks biotechnology firms with at least one FDA-approved drug therapy, excluding fees and expenses. As of April 18, the fund possesses $17.84 million in net assets, with an expense ratio of 0.79%.

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) holds the largest position in the Virtus LifeSci Biotech Products ETF (NYSE:BBP). Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is an American biopharmaceutical company specializing in the development and commercialization of innovative treatments for eye care.

Insider Monkey’s fourth-quarter database reveals that 18 hedge funds maintained long positions in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), down from 20 funds in the previous quarter.